Elevated hepatic SULT1E1 activity in mouse models of cystic fibrosis alters the regulation of estrogen responsive proteins

Journal of Cystic Fibrosis

Volumn 6, Issue 1, 2007, Pages 23-30

  Li, Li ^a   Falany, Charles N ^a  

^a University of Alabama at Birmingham   (United States)

Author keywords

estradiol; CF liver disease; Cystic fibrosis transmembrane conductance regulator; Sulfotransferase

Indexed keywords

CARBONATE DEHYDRATASE III; CYTOCHROME P450 2B9; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTROGEN SULFOTRANSFERASE; GLUTATHIONE TRANSFERASE P1; LIVER ENZYME; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; KNOCKOUT MOUSE; LIVER CELL; LIVER DISEASE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REGULATORY MECHANISM;

ANIMALS; CELL LINE; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; DISEASE MODELS, ANIMAL; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTROGENS; HEPATOCYTES; HUMANS; LIVER DISEASES; MICE; MICE, INBRED CFTR; MICE, KNOCKOUT; SULFOTRANSFERASES;

EID: 33846005168     PISSN: 15691993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcf.2006.05.001     Document Type: Article

References (41)

1. Berschneider H.M., Knowles M.R., Azizkhan R.G., Boucher R.C., Tobey N.A., Orlando R.C., et al. Altered intestinal chloride transport in cystic fibrosis. FASEB J 2 (1988) 2625-2629
2. Trezise A.E., and Buchwald M. In vivo cell-specific expression of the cystic fibrosis transmembrane conductance regulator. Nature 353 (1991) 434-437
3. FitzSimmons S.C. The changing epidemiology of cystic fibrosis. J Pediatr 122 (1993) 1-9
4. Lamireau T., Monnereau S., Martin S., Marcotte J.E., Winnock M., and Alvarez F. Epidemiology of liver disease in cystic fibrosis: a longitudinal study. J Hepatol 41 (2004) 920-925
5. Flora K.D., and Benner K.G. Liver disease in cystic fibrosis. Clin Liver Dis 2 (1998) 51-61
6. Feranchak A.P. Hepatobiliary complications of cystic fibrosis. Curr Gastroenterol Rep 6 (2004) 231-239
7. Kelly D.A. Managing liver failure. Postgrad Med J 78 (2002) 660-667
8. Lagrange-Puget M., Durieu I., Ecochard R., Abbas-Chorfa F., Drai J., Steghens J.T., et al. Longitudinal study of oxidative status in 312 cystic fibrosis patients in stable state and during bronchial exacerbation. Pediatr Pulmonol 38 (2004) 43-49
9. Falany C.N. Enzymology of human cytosolic sulfotransferases. FASEB J 11 (1997) 206-216
10. Song W.C. Biochemistry and reproductive endocrinology of estrogen sulfotransferase. Ann N Y Acad Sci 948 (2001) 43-50
11. Kotov A., Falany J.L., Wang J., and Falany C.N. Regulation of estrogen activity by sulfation in human Ishikawa endometrial adenocarcinoma cells. J Steroid Biochem Mol Biol 68 (1999) 137-144
12. Falany J.L., Greer H., Kovacs T., Sorscher E.J., and Falany C.N. Elevation of hepatic sulphotransferase activities in mice with resistance to cystic fibrosis. Biochem J 364 (2002) 115-120
13. Koller B.H., Kim H.S., Latour A.M., Brigman K., Boucher Jr. R.C., Scambler P., et al. Toward an animal model of cystic fibrosis: targeted interruption of exon 10 of the cystic fibrosis transmembrane regulator gene in embryonic stem cells. Proc Natl Acad Sci U S A 88 (1991) 10730-10734
14. Du M., Jones J.R., Lanier J., Keeling K.M., Lindsey J.R., Tousson A., et al. Aminoglycoside suppression of a premature stop mutation in a Cftr-/-mouse carrying a human CFTR-G542X transgene. J Mol Med 80 (2002) 595-604
15. Falany C.N., Krasnykh V., and Falany J.L. Bacterial expression and characterization of a cDNA for human liver estrogen sulfotransferase. J Steroid Biochem Mol Biol 52 (1995) 529-539
16. Song W.C., Qian Y., Sun X., and Negishi M. Cellular localization and regulation of expression of testicular estrogen sulfotransferase. Endocrinology 138 (1997) 5006-5012
17. He D., Meloche C.A., Dumas N.A., Frost A.R., and Falany C.N. Different subcellular localization of sulphotransferase 2B1b in human placenta and prostate. Biochem J 379 (2004) 533-540
18. Xu J., Ji S., Venable D.Y., Franklin J.L., and Messina J.L. Prolonged insulin treatment inhibits GH signaling via STAT3 and STAT1. Endocrinology 184 (2005) 481-492
19. Cohn J.A., Strong T.V., Picciotto M.R., Nairn A.C., Collins F.S., and Fitz J.G. Localization of the cystic fibrosis transmembrane conductance regulator in human bile duct epithelial cells. Gastroenterology 105 (1993) 1857-1864
20. Alpini G., Ulrich C., Roberts S., Phillips J.O., Ueno V., Podila P.V., et al. Molecular and functional heterogeneity of cholangiocytes from rat liver after bile duct ligation. Am J Physiol 272 (1997) G289-G297
21. Osborne C.K., Schiff R., Fuqua S.A., and Shou J. Estrogen receptor: current understanding of its activation and modulation. Clin Cancer Res 7 (2001) 4338s-4342s
22. Katzenellenbogen B.S., Montano M.M., Ediger T.R., Sun J., Ekena K., Lazennec G., et al. Estrogen receptors: selective ligands, partners, and distinctive pharmacology. Recent Prog Horm Res 55 (2000) 163-193
23. Zhang H., Varlamova O., Vargas F.M., Falany C.N., and Leyh T.S. Sulfuryl transfer: the catalytic mechanism of human estrogen sulfotransferase. J Biol Chem 273 (1998) 10888-10892
24. Falany J.L., Macrina N., and Falany C.N. Regulation of MCF-7 breast cancer cell growth by beta-estradiol sulfation. Breast Cancer Res Treat 74 (2002) 167-176
25. Kelly V.P., Ellis E.M., Manson M.M., Channas S.A., Moffat G.J., McLeod R., et al. Chemoprevention of aflatoxin B1 hepatocarcinogenesis by coumarin, a natural benzopyrone that is a potent inducer of aflatoxin B1-aldehyde reductase, the glutathione S-transferase A5 and P1 subunits, and NAD(P)H:quinone oxidoreductase in rat liver. Cancer Res 60 (2000) 957-969
26. Schuetz E.G., Schmid W., Schutz G., Brimer C., Yasuda K., Kamataki T., et al. The glucocorticoid receptor is essential for induction of cytochrome P450 2B by steroids but not for drug or steroid induction of CYP3A or P-450 reductase in mouse liver. Drug Metab Dispos 28 (2000) 268-278
27. Honkakoski P., Kojo A., and Lang M.A. Regulation of the mouse liver cytochrome P450 2B subfamily by sex hormones and phenobarbital. Biochem J 285 (1992) 979-983
28. Feranchak A.P., and Sokol R.J. Cholangiocyte biology and cystic fibrosis liver disease. Semin Liver Dis 21 (2001) 471-488
29. Henrion-Caude A., Flamant C., Roussey M., Housset C., Flahault A., Fryer A.A., et al. Liver disease in pediatric patients with cystic fibrosis is associated with glutathione S-transferase P1 polymorphism. Hepatology 36 (2002) 913-917
30. Salvatore F., Scudiero O., and Castaldo G. Genotype-phenotype correlation in cystic fibrosis: the role of modifier genes. Am J Med Genet 111 (2002) 88-95
31. Durie P.R., Kent G., Phillips M.J., and Cameron AA. Characteristic multiorgan pathology of cystic fibrosis in a long-living cystic fibrosis transmembrane regulator knockout murine model. Am J Pathol (2004) 1481-1493
32. Nilsson S., Makela S., Treuter E., Tujague M., Thomsen J., Andersson G., et al. Mechanisms of estrogen action. Physiol Rev 81 (2001) 1535-1565
33. Montano M.M., Deng H., Liu M., Sun X., and Singal R. Transcriptional regulation by the estrogen receptor of antioxidative stress enzymes and its functional implications. Oncogene 23 (2004) 2442-2453
34. Cabiscol E., and Levine R.L. Carbonic anhydrase III. Oxidative modification in vivo and loss of phosphatase activity during aging. J Biol Chem 270 (1995) 14742-14747
35. Fanjul M., Salvador C., Alvarez L., Cantet S., and Hollande E. Targeting of carbonic anhydrase IV to plasma membranes is altered in cultured human pancreatic duct cells expressing a mutated (deltaF508) CFTR. Eur J Cell Biol 81 (2002) 437-447
36. Lee K.H., Finnigan-Bunick C., Bahr J., and Bunick D. Estrogen regulation of ion transporter messenger RNA levels in mouse efferent ductules are mediated differentially through estrogen receptor (ER) alpha and ER beta. Biol Reprod 65 (2001) 1534-1541
37. Hudson V.M. New insights into the pathogenesis of cystic fibrosis: pivotal role of glutathione system dysfunction and implications for therapy. Treat Respir Med 3 (2004) 353-363
38. Rushmore T.H., and Kong A.N. Pharmacogenomics, regulation and signaling pathways of phase I and II drug metabolizing enzymes. Curr Drug Metab 3 (2002) 481-490
39. Jarukamjorn K., Sakuma T., and Nemoto N. Discriminating activation of CYP2B9 expression in male C57BL/6 mouse liver by beta-estradiol. Biochem Biophys Res Commun 279 (2000) 288-292
40. Ansell P.J., Espinosa-Nicholas C., Curran E.M., Judy B.M., Phillips B.J., Hannink M., et al. In vitro and in vivo regulation of antioxidant response element-dependent gene expression by estrogens. Endocrinology 145 (2004) 311-317
41. Garg L.C. Induction of hepatic carbonic anhydrase by estrogen. J Pharmacol Exp Ther 192 (1975) 297-302